AU11 Xanthohumol Benefits and Availability
Have a look at our PowerPoint Introduction and Brochure describing deliverables, differentiators and case studies. Eight case studies can also be reviewed.
The main contents of the study were based on sources including in-house databases and an extensive network of contacts in addition to publicly available information (e.g. data from government agencies, patents, scientific journals, trade press, internet etc.). Additional information was sought from other key resources within the industries concerned in sufficient depth to provide accurate analysis and guidance.
CPL used its extensive network of contacts, (including the CPL Executive Search network), to elicit information that would be difficult or impossible for clients to obtain independently Interviews were conducted with those knowledgeable in the industry, both face-to-face and telephone conversations. Contacts were also made at trade-shows.
The report consists of two parts, the summary report and the reference report, to provide the essence of CPL’s findings along with our recommendations, followed by detailed data sources and analysis.
Table of Contents
PUReOPE Opportunities with Xanthohumol and Related Compounds
Players Products and Patent Applications
XN and Derivatives as an in Vivo Antioxidant
11 Hop Players and Suppliers
Recent Articles and News
Nematodes and Polyphenols
Microbial and Dietary Activation
Tissue Related Inflamation